|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/351 | |
| A61P 35/00 | |||
| A61K 33/26 | |||
| A61P 1/04 | |||
| A61P 3/02 | |||
| A61P 43/00 | |||
| A61P 7/06 |
| (11) | Number of the document | 3435999 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17714766.7 |
| Date of filing the European patent application | 2017-03-31 | |
| (97) | Date of publication of the European application | 2019-02-06 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/057705 |
| Date | 2017-03-31 |
| (87) | Number | WO 2017/167972 |
| Date | 2017-10-05 |
| (30) | Number | Date | Country code |
| 201605474 | 2016-03-31 | GB |
| (72) |
POWELL, Jonathan, Joseph, GB
PEREIRA, Dora, I.A., GB
|
| (73) |
Shield TX (UK) Limited,
Northern Design Centre Baltic Business Quarter Gateshead Tyne And Wear, NE8 3DF,
GB
|
| (54) | FERRIC MALTOL COMPOSITIONS FOR USE IN THE TREATMENT OR PREVENTION OF CANCER AND TUMOURS |
| FERRIC MALTOL COMPOSITIONS FOR USE IN THE TREATMENT OR PREVENTION OF CANCER AND TUMOURS |